Abstract:
The present invention is for an isolated peptide consisting of the amino acid sequence of SEQ ID NO: 9 and using the peptide for treating asthma by reducing cytotoxicity of eosinophil derived toxins in bronchial epithelial cells of the subject suffers from asthma. The method comprises preparing a pharmaceutical composition having the peptide of SEQ ID NO: 9 and administering an effective amount of the composition to the subject.
Abstract translation:本发明涉及由SEQ ID NO:9的氨基酸序列组成的分离的肽,并且通过降低患有哮喘的受试者的支气管上皮细胞中嗜酸性粒细胞来源的毒素的细胞毒性,并且使用该肽来治疗哮喘。 该方法包括制备具有SEQ ID NO:9的肽的药物组合物,并向受试者施用有效量的组合物。
Abstract:
The present invention relates to an antibody mimetic of carbohydrate binding module (CBM) which specifically binds to an epitope on HIV glycoprotein. The present invention also relates to a method of detecting HIV glycoprotein.
Abstract:
The present invention relates to an antibody mimetic of carbohydrate binding module (CBM) which specifically binds to an epitope on HIV glycoprotein. The present invention also relates to a method of detecting HIV glycoprotein.
Abstract:
A process for making Biolimus A9 comprises reacting sirolimus (or rapamycin) with alkyl benzene sulfonate under the catalyzing of organic base and in the presence of organic solvent to undergo a nucleophilic substitution reaction to obtain the Biolimus A9 with high yield, not only for small-scale laboratory experiment, but also for rendering reproducibility of high yield even after process amplification.
Abstract:
The present invention provides a cell penetrating peptide which has following sequence: NYBX1BX2BNQX3, wherein B represents a basic amino acid, X1 represents an amino acid with an aromatic, a hydrophobic or an uncharged side chain, X2 represents any amino acid, and X3 represents N or none. The present invention also provides a method for delivering a cargo into a subject by administrating a complex comprising the cell penetrating peptide and the desired cargo to the subject.
Abstract:
A process for making Biolimus A9 comprises reacting sirolimus (or rapamycin) with alkyl benzene sulfonate under the catalyzing of organic base and in the presence of organic solvent to undergo a nucleophilic substitution reaction to obtain the Biolimus A9 with high yield, not only for small-scale laboratory experiment, but also for rendering reproducibility of high yield even after process amplification.
Abstract:
The present invention discloses a bidirectional transmission network apparatus based on a tunable rare-earth-doped fiber laser source. It is useful in wavelength-division-multiplexing access networks. The fiber ring laser not only generates downstream data traffic but also serves as the wavelength-selecting injection light source for the Fabry-Pérot lasers (or vertical cavity surface emitting lasers) located at the subscriber site. The fiber laser is constructed based on optical filtering, polarization control and noise suppression techniques.
Abstract:
The present invention is for an isolated peptide consisting of the amino acid sequence of SEQ ID NO: 9 and using the peptide for treating asthma by reducing cytotoxicity of eosinophil derived toxins in bronchial epithelial cells of the subject suffers from asthma. The method comprises preparing a pharmaceutical composition having the peptide of SEQ ID NO: 9 and administering an effective amount of the composition to the subject.
Abstract translation:本发明涉及由SEQ ID NO:9的氨基酸序列组成的分离的肽,并且通过降低患有哮喘的受试者的支气管上皮细胞中嗜酸性粒细胞来源的毒素的细胞毒性,并且使用该肽来治疗哮喘。 该方法包括制备具有SEQ ID NO:9的肽的药物组合物,并向受试者施用有效量的组合物。